title: Combination therapy in metastatic renal cell carcinoma.
authors.affiliation: Department of Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Canada. daniel.heng@albertahealthservices.ca
authors.forename: Daniel Y C
authors.initials: DY
authors.lastname: Heng
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols; D000068258:Bevacizumab; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016898:Interferon-alpha; D000068258:Bevacizumab; C401859:temsirolimus; D020123:Sirolimus